ASELSAN: Turkey's Defense Electronics Giant and Strategic National Asset

SU
surgeon1
Not Invested
Community Contributor
Published
08 Apr 25
Updated
08 Apr 25
surgeon1's Fair Value
₺16,572.31
99.0% undervalued intrinsic discount
08 Apr
₺166.20
Loading
1Y
163.8%
7D
7.9%

Author's Valuation

₺16.6k

99.0% undervalued intrinsic discount

surgeon1's Fair Value

Key aspects of ASELSAN

  1. Foundation and ownership: The Turkish Armed Forces Foundation created it, and it still maintains a majority stake (around 74-75%) in the company. ASELSAN was publicly listed on the Istanbul Stock Exchange (Borsa Istanbul) in 1990.
  2. Growth and expansion: From its initial focus on military communication systems, ASELSAN has expanded into numerous defense technology areas, including radar systems, electronic warfare, electro-optics, avionics, unmanned systems, and missile technologies.
  3. Strategic importance: The company has become a cornerstone of Turkey's defense industry strategy, emphasizing self-sufficiency in critical military technologies. ASELSAN is one of Turkey's most strategically important companies.
  4. International presence: While primarily serving the Turkish Armed Forces, ASELSAN has expanded internationally with exports to numerous countries and has subsidiaries or joint ventures in several nations.
  5. Financial performance: ASELSAN has generally shown strong financial growth, particularly as Turkey has increased defense spending and prioritized domestic procurement. The stock has been considered a stable investment within the Turkish market.
  6. R&D focus: The company invests significantly in research and development, operating several R&D centers and collaborating with Turkish universities.

As one of Turkey's largest industrial enterprises and a key player in the growing Turkish defense sector, ASELSAN's stock has attracted interest from both domestic and international investors looking for exposure to the defense industry and the Turkish market

How well do narratives help inform your perspective?

Disclaimer

The user surgeon1 holds no position in IBSE:ASELS. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives